Home > publication, Research Impact and Quality, Returns on R and D Investments, science education, science impact > Some links to interesting stories: multitasking, genes, SFI, start-ups, Obama’s Science advisors and some fraud

Some links to interesting stories: multitasking, genes, SFI, start-ups, Obama’s Science advisors and some fraud

The brain can do as many as two things at once!

So you think you can multitask?

Motivated Multitasking: How the Brain Keeps Tabs on Two Tasks at Once
New research shows that rather than being totally devoted to one goal at a time, the human brain can distribute two goals to different hemispheres to keep them both in mind–if it perceives a worthy reward for doing so.

The cancer-yeast connection:

The Search for Genes Leads to Unexpected Places By CARL ZIMMER
Edward M. Marcotte is looking for drugs that can kill tumors by stopping blood vessel growth, and he and his colleagues at the University of Texas at Austin recently found some good targets — five human genes that are essential for that growth. Now they’re hunting for drugs that can stop those genes from working. Strangely, though, Dr. Marcotte did not discover the new genes in the human genome, nor in lab mice or even fruit flies. He and his colleagues found the genes in yeast.

Science Foundation Ireland’s latest grant round (and Dick Ahlstrom’s story in the Irish Times)

Two good news start-up stories:

Start-ups gaining from technology recovery;Two founders share €11m in sale of Irish bio company

Obama’s science advisors (Jeff Akst reports):

The three co-chairs: John Holdren, Assistant to the President for Science and Technology and director of the Office of Science and Technology Policy; Eric Lander, professor at both Massachusetts Institute of Technology and Harvard Medical School; and Harold Varmus, president of Memorial Sloan-Kettering Cancer Center.

The other 18 members of PCAST are as follows:

Rosina Bierbaum, Dean of the School of Natural Resources and Environment at the University of Michigan

Christine Cassel, president and CEO of the American Board of Internal Medicine

Christopher Chyba, professor of astrophysical sciences and international affairs at Princeton University and a member of the Committee on International Security and Arms Control of the National Academy of Sciences

S. James Gates Jr., professor of physics and director of the Center for String and Particle Theory at the University of Maryland, College Park

Shirley Ann Jackson, president of Rensselaer Polytechnic Institute and former Chair of the US Nuclear Regulatory Commission

Richard Levin, president of Yale University

Chad Mirkin, professor of chemistry in the Weinberg College of Arts and Sciences and director of Northwestern’s International Institute of Nanotechnology

Mario Molina, professor of chemistry and biochemistry at the University of California, San Diego and the Center for Atmospheric Sciences at the Scripps Institution of Oceanography, and 1995 chemistry Nobel laureate

Ernest J. Moniz, professor of physics and engineering systems, director of the Energy Initiative, and director of the Laboratory for Energy and the Environment at MIT

Craig Mundie, Chief Research and Strategy Officer at Microsoft Corp

Ed Penhoet, a director of Alta Partners, and chairman of the Board for Immune Design and Metabolex

William Press, professor of computer sciences at the University of Texas at Austin

Maxine Savitz, retired general manager of Technology Partnerships at Honeywell, Inc

Barbara Schaal, distinguished professor at Washington University and vice president of the National Academy of Sciences

Eric Schmidt, chairman and CEO of Google Inc. and a member of the Board of Directors of Apple Inc.

Daniel Schrag, professor of geology at Harvard University and professor of environmental science and engineering in the School of Engineering and Applied Sciences

David E. Shaw, chief scientist of D. E. Shaw Research and founder of D. E. Shaw & Co., an investment and technology development firm

Ahmed Zewail, professor of chemistry and physics at Caltech, director of the Physical Biology Center, and 1999 Nobel laureate in chemistry

By Jef Akst, Associate Editor, The Scientist

Some scientific fraud: Two papers (one highly cited) on the mechanism of estrogen signaling have been retracted after an investigation by Wyeth found that the research data of its former employee Boris Cheskis were “unreliable.”
  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 457 other followers

%d bloggers like this: